(Source: Sabatella et al., Obesity , 2026) Why the Gap Is Partly About Adherence, Not Just the Drug The most important context for these numbers is one the lead researchers themselves emphasized: much of the observed gap reflects how GLP-1 therapy is actually used in the real world, not a ceiling on what the medication can achieve
Battling chronic hunger, poor energy, or inflammation
The 0.9% standard represents the established balance that the research community relies on, and medical-grade manufacturing ensures precise formulation
This product is not approved by the FDA to diagnose, treat, cure, or prevent any disease and is not intended for human or animal consumption
Funct Ecol
Journal of Dermatological Science, 35(3), 147157.